AIM ImmunoTech Inc - Company Profile

Powered by

All the sales intelligence you need on AIM ImmunoTech Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how AIM ImmunoTech Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with AIM ImmunoTech Inc.

Back to companies

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on AIM ImmunoTech Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into AIM ImmunoTech Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

William M. Mitchell, M.D., Ph.D.

Chairman Executive Board Since: 2016 Age: 90

Dr. William M. Mitchell has been the Chairman of the company since 2016. Prior to this, he served as the Director since 1998; Professor of Pathology, Microbiology and Immunology at Vanderbilt University School of Medicine and is a board certified physician. Previously, he served as the Osler House Officer in Internal Medicine at the Johns Hopkins Hospital, followed by a Fellowship at its School of Medicine.

Read Hide full bio of William M. Mitchell, M.D., Ph.D.

Thomas K. Equels

President; Vice Chairman; Chief Executive Officer Senior Management Age: 73

Mr. Thomas K. Equels has been the Chief Executive Officer, President, and Vice Chairman of the company since 2016. Prior to this, he served as the President and Managing Director of the Equels Law Firm.

Read Hide full bio of Thomas K. Equels

Robert Dickey IV

Chief Financial Officer Senior Management Since: 2022 Age: 70

Mr. Robert Dickey IV has been the Chief Financial Officer of the company since 2022. Prior to this, he served as the Senior Vice President of the company. Previously, he served as the Managing Director at Foresite Advisors. Mr. Dickey also serves as a member on the Board of Directors of AngioGenex, SFA Therapeutics, and GSNO Therapeutics.

Read Hide full bio of Robert Dickey IV

Peter W. Rodino III

Secretary; Chief Operating Officer; General Counsel Senior Management Since: 2019 Age: 74

Mr. Peter W. Rodino has been the Chief Operating Officer, General Counsel and Secretary of the company since 2019. Prior to this, he served as the Chairman and Chief Executive Officer of Crossroads Health Plan.

Read Hide full bio of Peter W. Rodino III

Christopher Nicodemus, M.D.

Consulting Science Officer Senior Management
Gain a 360-degree view of AIM ImmunoTech Inc and make more informed decisions for your business Gain a 360-degree view of AIM ImmunoTech Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer